iBio Inc. stock falls Wednesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock falls Tuesday, underperforms market | news.google.com • |
iBio Inc. stock outperforms market despite losses on the day | news.google.com • |
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | -0.46 | N/A | N/A | N/A |
2024-05-13 | 2024-03 | 0 | -0.71 | N/A | N/A |
2024-02-09 | 2023-12 | 0 | -2.42 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -4.2 | N/A | N/A |
2023-10-10 | 2023-06 | 0 | N/A | N/A | N/A |
2023-07-06 | 2023-03 | 0 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-31 | BRENNER MARTIN | Chief Executive Officer | 182.50K | Sale |
2014-09-16 | DESANTIS CARL R | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-03-30 | DURAN FELIPE | Chief Financial Officer | 39.63K | Stock Award(Grant) |
2020-08-10 | EASTERN CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2020-06-03 | ERWIN ROBERT L | President | 108.11K | Sale |
2020-03-18 | ISETT THOMAS FRANCIS III | Chief Executive Officer | 1.27M | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 512.28K | 312.49K | 1.86% |
2023-06-29 | Avantax Planning Partners, Inc. | 155.00K | 94.55K | 0.56% |
2023-06-29 | Blackrock Inc. | 137.94K | 84.14K | 0.50% |
2023-06-29 | Bank Of New York Mellon Corporation | 87.47K | 53.36K | 0.32% |
2023-06-29 | Geode Capital Management, LLC | 76.29K | 46.53K | 0.28% |
2023-06-29 | Renaissance Technologies, LLC | 46.10K | 28.12K | 0.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 336.21K | 205.09K | 1.22% |
2023-06-29 | Vanguard Extended Market Index Fund | 165.75K | 101.11K | 0.60% |
2023-05-30 | Fidelity Extended Market Index Fund | 46.85K | 32.80K | 0.17% |
2023-05-30 | Fidelity Total Market Index Fund | 13.73K | 9.61K | 0.05% |
2023-05-30 | Fidelity Series Total Market Index Fund | 9.49K | 6.64K | 0.03% |
2023-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 7.28K | 4.44K | 0.03% |
Split | Date |
---|---|
1 : 20 | 2023-11-29 |
1 : 25 | 2022-10-10 |
1 : 10 | 2018-06-11 |
-
IBIO EVENTS :IPF Summit Digital August 24-26, 2020 ,Online Event, KC Animal Heath Summit,August 31 – September 2, 2020. Just remember that IBIO and fast farming was created to make vaccine very fast in case of a pandemic,now this COVID-19 virusu is all over the world,other companies will stay in line to get a contract with IBIO, do to their fast farming,contracts with IBIO will happen very soon in the future and this stock will skyrocket.
-
Just remember that IBIO and fast farming was created to make vaccine very fast in case of a pandemic,now this COVID-19 virusu is all over the world,other companies will stay in line to get a contract with IBIO, do to their fast farming,contracts with IBIO will happen very soon in the future and this stock will skyrocket
-
Better pray to go down, missing the boat is a sad part. Waiting is not an issue as long as you are in.
-
Bears, did you guys see this?
-
Lesson learned: I will never do the same mistakes again I did with KBIO (2015), MRNA (2020) and NVAX (2020). Long is the answer! Higher risk but better reward!!!
Below are my lucky charm
IBIO - my winning Lottery
BOXL - my winning Lottery
MRNA - my dream house
BNTX - my dream house -
Anyone knows what settings it is? I have problem attaching pictures here and some special characters like hyphen. Not sure what I am missing from the settings.
-
I was wrong today it did not hit 5$... hopefully tomorrow...
We’ll see...
-
Hey number 2 better suck balls cause u love nut
-
Last call!!!! Get in Bears!
-
iBio Pharma (NYSEAMERICAN:IBIO) news for Monday concerning an update about the novel coronavirus has IBIO stock soaring higher.
The update comes from president Donald Trump during a conference on Sunday. During that conference, the President announced that the U.S. Food & Drug Administration (FDA) has approved emergency use authorization for convalescent plasma therapy to treat some people suffering from the coronavirus.
According to President Trump, the authorization from the FDA will cover coronavirus patients that are hospitalized due to the illness. This opens up the way for plasma companies to use plasma from people previously infected by the virus to treat those currently being affected by it.
Convalescent plasma therapy uses plasma to treat patients because it contains antibodies.That means that people that have already had the coronavirus have the appropriate antibodies to fight the virus off. Transferring this plasma to a person already infected by the virus can help their bodies naturally fight it off.
This news affects iBio Pharma because it’s one of those plasma companies. While iBio Pharma typically focuses on vaccines from plant proteins, it has used its research in the past for human plasma treatments, reports The Motley Fool. -
Good run at IBIO today, the big companies are starting to buy IBIO again, a big contract will come very soon
-
iBio Pharma (NYSEAMERICAN:IBIO) news for Monday concerning an update about the novel coronavirus has IBIO stock soaring higher.
The update comes from president Donald Trump during a conference on Sunday. During that conference, the President announced that the U.S. Food & Drug Administration (FDA) has approved emergency use authorization for convalescent plasma therapy to treat some people suffering from the coronavirus.
According to President Trump, the authorization from the FDA will cover coronavirus patients that are hospitalized due to the illness. This opens up the way for plasma companies to use plasma from people previously infected by the virus to treat those currently being affected by it.
Convalescent plasma therapy uses plasma to treat patients because it contains antibodies.That means that people that have already had the coronavirus have the appropriate antibodies to fight the virus off. Transferring this plasma to a person already infected by the virus can help their bodies naturally fight it off.
This news affects iBio Pharma because it’s one of those plasma companies. While iBio Pharma typically focuses on vaccines from plant proteins, it has used its research in the past for human plasma treatments, reports The Motley Fool. -
No rocket still lol
-
Load, load, load
-
PR is in Wednesday- so get on board.
-
I am expecting to hit 5$ dollars closing time today before the big news that can ramp up probably 10$ this week.
Lets Go!
-
Lets GO!!!
Lesson learned: I will never do the same mistakes again I did with KBIO (2015), MRNA (2020) and NVAX (2020). Long is the answer! Higher risk but better reward!!!
Below are my lucky charm
IBIO - my winning Lottery
BOXL - my winning Lottery
MRNA - my dream house
BNTX - my dream house -
Lets Go!!!
Lesson learned: I will never do the same mistakes again I did with KBIO (2015), MRNA (2020) and NVAX (2020). Long is the answer! Higher risk but better reward!!!
Below are my lucky charm
IBIO - my winning Lottery
BOXL - my winning Lottery
MRNA - my dream house
BNTX - my dream house
-
iBio Inc. stock falls Wednesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock falls Tuesday, underperforms market
news.google.com • -
iBio Inc. stock outperforms market despite losses on the day
news.google.com • -
iBio, Inc. (NYSEAMERICAN:IBIO) Short Interest Update
news.google.com • -
iBio Inc. stock rises Friday, outperforms market
news.google.com • -
iBio Inc. stock rises Thursday, still underperforms market
news.google.com •